NPI registry status
Active
2026 NPPES data Pulmonary Disease Physician NPI 1346500576
Verify on CMS → Lucas Kimmig
Pulmonary Disease Physician in Chicago, Illinois.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,647 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
434
Medicare Part D claims · 93 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
26%
generic claims · 74% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
97.7/100
▲ 14 pts above national avg 83.5 · Exceptional
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Lucas Kimmig reported a CMS MIPS final score of 97.7/100 - above the 83.5 national average - and filed 434 Medicare Part D claims in 2024.
- 97.7/100
- MIPS score · +14 vs avg
- 434
- Part D claims, 2024
- 26%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Lucas Kimmig
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1346500576), first enumerated 05/22/2012.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 434 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 97.7/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
2 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- State context
State board disciplinary context
Illinois statewide board action statistics are published annually — these figures describe aggregate state activity, not Lucas Kimmig's individual license status. Verify directly with the state medical board.
Source: IDFPR annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1346500576 · Pulmonary Disease Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-ELITE · RX-LIGHT · BOOK-THIN · PHOTO-FINISH
- NPI-10 1346500576
- ENUM-MID 2012
- TAX-MID 10K Pulmonary Disease
- MIPS-ELITE 97.7/100
- RX-LIGHT 434
- BOOK-THIN 365 in Illinois
- PHOTO-FINISH Remzi Bag · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Kimmig · this pr…
Kimmig · this provider
97.7 MIPS pts
- Remzi Bag · near
Remzi Bag
97.7 MIPS pts
- Ravinder Gandhi,…
Ravinder Gandhi, M.D.
97.8 MIPS pts
- Alanna Neves, AC…
Alanna Neves, ACNP
97.8 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Lucas Kimmig's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
98 ≥ 84th percentile 84% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Lucas Kimmig sits
This provider among pulmonary disease physician peers
Across the 2,467 pulmonary disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, Lucas Kimmig writes more Part D claims than 31% of them and scores higher on MIPS quality than 87% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one pulmonary disease physician peer from a representative sample of 60; the gold marker is Lucas Kimmig. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Lucas Kimmig practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Lucas Kimmig?
High performer (top quartile)Primary specialty
Pulmonary Disease Physician
Medicare Part D claims
434 71% vs specialty avg
MIPS final score
97.7/100 14.2 pts vs avg
Specialty distribution in Illinois
How Pulmonary Disease Physician compares to other specialties among Illinois providers
Medicare quality performance, MIPS
Lucas Kimmig's 2023 MIPS final score plotted against the Pulmonary Disease Physician national average
- MIPS Final Score
- 97.7/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1346500576 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Gender | Male |
| NPI Issued | 05/22/2012 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
97.7188
Final Score
Measured-score avg: 83.5
75.4375
Quality
100
Promoting Interoperability
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where Lucas Kimmig bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
The University OF Chicago Medical Center
★★★★☆ 4/5
Chicago, IL
Acute Care Hospitals
CMS CCN: 140088
University OF Chicago
Chicago, IL
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context - Illinois IDFPR 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~42K Illinois medical licensees in 2023 - they are NOT specific to Lucas Kimmig. To verify Lucas Kimmig's current license status, search the IDFPR public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
106
Total board actions, Illinois 2023
Across 103 cases
2.52
Actions per 1,000 licensees
Illinois statewide rate
probation
Most common action type
38 cases
IDFPR publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Illinois disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Lucas Kimmig - brand share 74.0%
Pulmonary Disease Physician average
74% brand-name claims vs 26% generic, on 434 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
434
Total Claims
$207K
Total Drug Cost
93
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 523.367
- Total Day Supply
- 14,057
- Brand vs Generic
- 74% brand / 26% generic
- Brand Drug Cost
- $201K
- Generic Drug Cost
- $6K
- Antibiotic Claims
- 25
Patient Demographics
- Average Patient Age
- 71.8 years
- Avg HCC Risk Score
- 2.17
- Gender Split
- 70% female / 30% male
- Age Distribution
- <65: 17, 65-74: N/A, 75-84: 35, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Lucas Kimmig prescribes most
Top Medicare Part D drugs by claim count, 2024
- Albuterol Sulfate …
Albuterol Sulfate Hfa
86 claims
- Anoro Ellipta
Anoro Ellipta
47 claims
- Incruse Ellipta
Incruse Ellipta
38 claims
- Symbicort 32
Symbicort
32 claims
- Breo Ellipta 24
Breo Ellipta
24 claims
- Prednisone 21
Prednisone
21 claims
- Azithromycin 20
Azithromycin
20 claims
- Trelegy Ellipta 18
Trelegy Ellipta
18 claims
| Drug | Claims |
|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 86 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 47 |
| Incruse Ellipta Umeclidinium Bromide | 38 |
| Symbicort Budesonide/Formoterol Fumarate | 32 |
| Breo Ellipta Fluticasone/Vilanterol | 24 |
| Prednisone | 21 |
| Azithromycin | 20 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 18 |
| Fasenra Pen Benralizumab | 14 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 14 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Lucas Kimmig fits within the Pulmonary Disease Physician landscape nationally.
9,647
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,498
Avg Claims per Provider
Lucas Kimmig's 434 claims are below the specialty average of 1,498.
Nationwide Pulmonary Disease Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Kimmig, both outside Illinois so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (97.7 here).
Same NPPES enumeration year (2012)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Pulmonary Disease Physician Providers in Illinois
Other clinicians with the same primary specialty enrolled in Illinois, drawn from the same CMS NPPES roster as Kimmig.
One of 365 Pulmonary Disease Physician providers enrolled in Illinois, 5 are shown here.
Dr. Mazen Abdel-Hadi
M.D.
Joliet, IL
Dr. Said Abuhasna
M.D
Elk Grove Village, IL
Dr. Katherine Acosta
MD
Chicago, IL
Ayodeji Adegunsoye
Chicago, IL
Dr. Ahmed Agameya
M.D
Peoria, IL
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Lucas Kimmig's specialty? ▼
Lucas Kimmig specializes in Pulmonary Disease Physician and practices in Chicago, Illinois.
How much does Lucas Kimmig prescribe under Medicare Part D? ▼
In 2024, Lucas Kimmig wrote 434 Medicare Part D claims totaling $207K in drug costs for 93 beneficiaries.
What is Lucas Kimmig's Medicare quality score? ▼
Lucas Kimmig has a CMS MIPS Final Score of 97.7/100 (Quality: 75.4). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Lucas Kimmig located? ▼
Lucas Kimmig is located at 5841 S MARYLAND AVE, Chicago, IL, 60637. Phone: (888) 824-0200.
What is Lucas Kimmig's NPI number? ▼
Lucas Kimmig's National Provider Identifier (NPI) is 1346500576, issued on 05/22/2012.
Does Lucas Kimmig prescribe more brand-name or generic drugs? ▼
Lucas Kimmig's prescribing is 74% brand-name and 26% generic drugs by claim count, with $201K in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US? ▼
There are 9,647 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,498 Medicare Part D claims per year.
What drugs does Lucas Kimmig prescribe most often? ▼
Based on 2024 Medicare Part D data, Lucas Kimmig's most frequently prescribed drugs include Albuterol Sulfate Hfa, Anoro Ellipta, Incruse Ellipta. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Lucas Kimmig accept Medicare? ▼
Lucas Kimmig appears in CMS Medicare data with 434 Part D claims and 93 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Lucas Kimmig's credentials? ▼
Lucas Kimmig's NPI is 1346500576. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.